S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Lantheus Holdings, Inc

LNTH XNAS
$93.06 +2.06 (+2.26%) ▲ 15-min delayed
Open
$91.79
High
$94.86
Low
$91.72
Volume
1.54M
Market Cap
$6.06B

About Lantheus Holdings, Inc

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Sector: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES Employees: 1.2K Website →

Key Financials

Period Revenue Net Income EPS
Q1 2026 $377.33M $118.42M $1.83
FY 2025 $1.54B $233.56M $3.46
Q3 2025 $384.01M $27.77M $0.41
Q2 2025 $378.05M $78.75M $1.15

Earnings & Analyst Ratings

Next Earnings: Tue, Aug 4, 2026
Calendar →

Related Market News

No specific coverage for LNTH yet. Check out our latest market news or earnings calendar.

Get LNTH Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Lantheus Holdings, Inc.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.